TY - JOUR
T1 - Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator
AU - Van Den Broeck, Tina
AU - Stevenaert, Frederik
AU - Taveirne, Sylvie
AU - Debacker, Veronique
AU - Vangestel, Christel
AU - Vandekerckhove, Bart
AU - Taghon, Tom
AU - Matthys, Patrick
AU - Plum, Jean
AU - Held, Werner
AU - Dewerchin, Mieke
AU - Yokoyama, Wayne M.
AU - Leclercq, Georges
PY - 2008/12/15
Y1 - 2008/12/15
N2 - The Ly49 natural killer (NK)-cell receptor family comprises both activating and inhibitory members, which recognize major histocompatibility complex (MHC) class I or MHC class I - related molecules and are involved in target recognition. As previously shown, the Ly49E receptor fails to bind to a variety of soluble or cell-bound MHC class I molecules, indicating that its ligand is not an MHC class I molecule. Using BWZ.36 reporter cells, we demonstrate triggering of Ly49E by the completely distinct, non-MHC-related protein urokinase plasminogen activator (uPA). uPA is known to be secreted by a variety of cells, including epithelial and hematopoietic cells, and levels are up-regulated during tissue remodeling, infections, and tumorigenesis. Here we show that addition of uPA to Ly49E-positive adult and fetal NK cells inhibits interferon-γ secretion and reduces their cytotoxic potential, respectively. These uPA-mediated effects are Ly49E-dependent, as they are reversed by addition of anti-Ly49E monoclonal antibody and by down-regulation of Ly49E expression using RNA interference. Our results suggest that uPA, besides its established role in fibrinolysis, tissue remodeling, and tumor metastasis, could be involved in NK cell-mediated immune surveillance and tumor escape.
AB - The Ly49 natural killer (NK)-cell receptor family comprises both activating and inhibitory members, which recognize major histocompatibility complex (MHC) class I or MHC class I - related molecules and are involved in target recognition. As previously shown, the Ly49E receptor fails to bind to a variety of soluble or cell-bound MHC class I molecules, indicating that its ligand is not an MHC class I molecule. Using BWZ.36 reporter cells, we demonstrate triggering of Ly49E by the completely distinct, non-MHC-related protein urokinase plasminogen activator (uPA). uPA is known to be secreted by a variety of cells, including epithelial and hematopoietic cells, and levels are up-regulated during tissue remodeling, infections, and tumorigenesis. Here we show that addition of uPA to Ly49E-positive adult and fetal NK cells inhibits interferon-γ secretion and reduces their cytotoxic potential, respectively. These uPA-mediated effects are Ly49E-dependent, as they are reversed by addition of anti-Ly49E monoclonal antibody and by down-regulation of Ly49E expression using RNA interference. Our results suggest that uPA, besides its established role in fibrinolysis, tissue remodeling, and tumor metastasis, could be involved in NK cell-mediated immune surveillance and tumor escape.
UR - http://www.scopus.com/inward/record.url?scp=58149398637&partnerID=8YFLogxK
U2 - 10.1182/blood-2008-06-164350
DO - 10.1182/blood-2008-06-164350
M3 - Article
C2 - 18784372
AN - SCOPUS:58149398637
SN - 0006-4971
VL - 112
SP - 5046
EP - 5051
JO - Blood
JF - Blood
IS - 13
ER -